(S)-4-Chloro-7-{2-oxo-2-[4-(2-oxo-2,3-dihydro-imidazo[4,5-b]pyridin-1-yl)-piperidin-1-yl]-ethyl}-1,9-bis-(2,2,2-trifluoro-ethyl)-1,3,6,7,9,10-hexahydro-1,3,9-triaza-cyclohepta[e]indene-2,8-dione

ID: ALA4875327

PubChem CID: 164628650

Max Phase: Preclinical

Molecular Formula: C28H26ClF6N7O4

Molecular Weight: 674.00

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(C[C@@H]1Cc2cc(Cl)c3[nH]c(=O)n(CC(F)(F)F)c3c2CN(CC(F)(F)F)C1=O)N1CCC(n2c(=O)[nH]c3ncccc32)CC1

Standard InChI:  InChI=1S/C28H26ClF6N7O4/c29-18-9-14-8-15(10-20(43)39-6-3-16(4-7-39)42-19-2-1-5-36-23(19)38-26(42)46)24(44)40(12-27(30,31)32)11-17(14)22-21(18)37-25(45)41(22)13-28(33,34)35/h1-2,5,9,15-16H,3-4,6-8,10-13H2,(H,37,45)(H,36,38,46)/t15-/m0/s1

Standard InChI Key:  VBZBTVHQXALNAJ-HNNXBMFYSA-N

Molfile:  

 
     RDKit          2D

 46 51  0  0  0  0  0  0  0  0999 V2000
   19.9015   -9.7155    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.6939   -9.9301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4836   -9.1365    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.9692  -10.9206    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.7658  -11.1353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5513  -10.3376    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.9425   -8.4608    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.3470   -9.1707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1601   -9.1733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5748   -8.4677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1662   -7.7578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3470   -7.7535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1212   -8.4602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7091   -7.7480    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.7079   -9.1717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8866   -9.1710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5342   -9.9039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7318  -10.0914    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.5329   -8.4298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0871   -9.5819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0888   -8.7617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7311   -8.2462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6066   -7.4357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8404   -7.1396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3259   -8.4688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2022   -7.6572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3919   -7.5211    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.0131   -8.2513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5920   -8.8359    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2012   -8.3791    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.0444  -10.5465    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.3935   -8.4739    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.5526  -10.8929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5850  -11.9377    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.7131   -6.3324    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   30.6548   -8.0706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8781   -7.8118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6299   -7.0332    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.6485   -8.8893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8679   -9.1345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6912   -9.9315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2943  -10.4842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0768  -10.2343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2497   -9.4378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4591   -9.6423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5616  -10.7367    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  4  1  0
  6  5  1  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 13  1  0
 13 14  2  0
 13 15  1  0
 16 15  1  1
 16 17  1  0
 17 18  1  0
 16 19  1  0
 18 20  1  0
 19 22  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 26  1  0
 25 21  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 25  1  0
 28 30  2  0
 17 31  2  0
 10 32  1  0
 18 33  1  0
 33  5  1  0
  5 34  1  0
 24 35  1  0
 32 40  1  0
 39 36  1  0
 36 37  1  0
 37 32  1  0
 37 38  2  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 44 39  1  0
 29 45  1  0
 45  2  1  0
  2 46  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4875327

    ---

Associated Targets(Human)

CALCRL Tclin Calcitonin gene-related peptide type 1 receptor (1509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 674.00Molecular Weight (Monoisotopic): 673.1639AlogP: 3.90#Rotatable Bonds: 5
Polar Surface Area: 129.09Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.68CX Basic pKa: 4.16CX LogP: 2.89CX LogD: 2.89
Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.31Np Likeness Score: -0.84

References

1. Luo G, Jiang XJ, Chen L, Conway CM, Gulianello M, Kostich W, Keavy D, Signor LJ, Chen P, Davis C, Whiterock VJ, Schartman R, Widmann KA, Macor JE, Dubowchik GM..  (2021)  Calcitonin gene-related peptide (CGRP) receptor antagonists: Heterocyclic modification of a novel azepinone lead.,  43  [PMID:33932522] [10.1016/j.bmcl.2021.128077]

Source